New: "Higher intakes of short- and long-chain SFAs, both individually and collectively, are associated with higher odds of MASLD." #saturatedfat #liverdisease #MASLD #hepatology
www.cambridge.org/core/journal...
AASLD is launching a NEW national initiative to improve early detection of liver fibrosis and #MASLD. @boehringerglobal.bsky.social serves as the lead supporter and primary funding partner for the project.
Learn more: https://bit.ly/41tjtye
#LiverHealth #Hepatology
🩺 Advancing metabolic-associated steatotic liver disease (MASLD) care: This study reviews emerging pharmacological therapies and future directions for MASLD management.
#MASLD #Hepatology #LiverDisease
www.xiahepublishing.com/2688-9254/JE...
Each 1 kg/m2 increase in maternal and paternal body mass index increased the odds of #MASLD among offspring by 10% and 9%, respectively.
Read More: https://bit.ly/3P8DUxG
As the role of #GLP1 therapies in #MASLD continues to grow, clinicians need clear guidance.
A new Practice Guidance update in #HEPATOLOGY provides evidence-based recommendations on using semaglutide therapy for MASH.
📗 View the update: https://bit.ly/4s4QM6A
Screening for metabolic dysfunction–associated steatotic liver disease is recommended for type 2 #diabetes. This case-based session improved knowledge of guideline-based #MASLD screening, FIB-4 interpretation, & indications for hepatology referral. #MedEd #MedSky
www.mededportal.org/doi/10.15766...
People with #MASLD can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 #diabetes, #cardiovascular disease, chronic #kidney disease, and extrahepatic cancers www.thelancet.com/journals/lan...
#T2D #CVD #CKD
#OpenAccess
#MedSky #EndoSky #LiverSky
⚕️Metabolic dysfunction–associated steatotic liver disease (MASLD) affects up to 1 in 3 adults in the United States and is one of the leading causes of liver failure. 👉 https://t2m.io/Y3JR6mw
#55pluslife #health #liverdisease #MASLD #fattyliver (#notfoiegras) #yourhealth
PLIN5 phosphorylation identified as a lever to tune hepatocyte lipid flux, suggesting therapeutic potential for targeting mitochondria–LD coupling #MASLD #MASH www.nature.com/articles/s42...
Estudi de la UVic-UCC i l’IDIBGI: els canvis en el microbioma intestinal indiquen la gravetat de la MASLD.
Marc Llirós forma part d’aquest equip investigador.
#microbioma #MASLD #recerca #UVicUCC #FCTE
✍️ “When the liver fails, the brain does not escape the consequences,” shares Dr Anna Hadjihambi (@KingsCollegeLon). Anna and her lab are unravelling brain dysfunction in #LiverDisease.
Read the blog to learn more about her research on #MASLD 🔗 www.physoc.org/blog/mind-ov...
Intermittent fasting helps rebalance metabolism by improving insulin sensitivity, gut health, and autophagy, reducing liver fat. Time‑restricted eating offers a practical, non‑drug strategy to protect liver health and curb MASLD’s rise.
medium.com/@AutophagyFa...
#MASLD #NAFLD #IntermittentFasting
📺 Rewatch the latest EASD Early Career Academy #webinar with Prof. Amalia Gastaldelli on what drives #MASLD & where treatments are headed. From metabolic to fibrotic pathways, get a deep dive into emerging therapeutic targets.
🎥👉 Watch here: www.youtube.com/watch?v=YYvZ...
#Diabetes #Research
The Canadian Liver Journal 9.1 presents notes from the Annual Canadian Liver Meeting 2026 of the Canadian Association for the Study of the Liver, the Canadian Network on Hepatitis C and CanMASLD.
Learn more: https://bit.ly/CanLivJ91k
#Hepatitis #Cirrhosis #MASLD
I teach medical students that fatty liver disease (MASLD) affects 1 in 3 adults and has limited approved drug treatments.
That may be changing.
Hebrew University researchers fo... www.sciencedaily.com/releases/2026/03/2603061...
#FattyLiver #MASLD #CBD #MetabolicHealth #LiverDisease
🔥HOT TOPIC in #HEPATOLOGY
Selected for its clinical impact, this meta-analysis delivers critical insights into which anti-diabetic therapies may also reduce liver-related events in patients with #MASLD.
Read the full study here: https://bit.ly/4s40EgD
Understanding MASLD: The Increasing Rise of Metabolic Liver Disease Explained by Dr. Karen Jerome-Zapadka #United_States #Liver_Disease #MASLD #Cranberry_Township #Dr._Jerome-Zapadka
The April 2026 issue of @lancetgastrohep.bsky.social is out today at www.thelancet.com/gastrohep
This month's issue features content on #IBD, #cirrhosis, #pancreaticcancer, #viralhepatitis, #MASLD + more...
#GastroSky #MedSky #LiverSky
#MASLD in kidney transplant recipients #KTR is associated with worse patient and graft survival
www.kireports.org/article/S2468-0249(26)02...
#transplant #medicine #nephrology
➡️ Nearly 1 in 3 #MASLD patients missed fibrosis risk–based care. Our study shows how AI-augmented workflows could reduce these gaps by automating steatosis detection, FIB-4 scoring, and referral alerts.
🔗 https://ow.ly/9T4u50YrxM2
🏷️ #FeaturedArticle
🧪 Did you know that 1 in 5 people living with #T2D have a degree of #fibrosis?
Prof. Kenneth Cusi urges clinicians to screen for and prevent #MASLD from progressing to cirrhosis #ADAConsensusReport.
📺 Watch the latest #ExpertInsights episode now: easd-elearning.eu/episode/361/...
#Liverhealth
Prenatal prednisone exposure promotes #MASLD in offspring via #GR-HDAC3-mediated #Serpina3c suppression, activating the #Chymase-AngII-AT1R axis to disrupt lipid metabolism, marking #Serpina3c as a critical #TherapeuticTarget.
#STTT #OpenAccess: doi.org/10.1038/s413...
#MASLD patients’ Health Literacy Questionnaire data were analyzed with clinical/demographic data. This suggested that lower health literacy is associated with more advanced MASLD/metabolic dysfunction.
🔗 https://ow.ly/HSjp50YrxF8
🏷️ #EditorsEssentialReading
#FIB-4 is widely used for #fibrosis assessment. But what about its changes over time?📈
🌏 A large international study shows how dynamic #FIB-4 may predict fibrosis progression and clinical outcomes in #MASLD
💡 Interesting implications for clinical practice!
📖: www.sciencedirect.com/science/arti...
#MASLD and #HBV overlap tackled in this article - lots of questions remaining in how to assess and treat this emerging dual threat to global #liver health 🧪
#MedSKy #LiverSky #HepSky #hepatitis
hepatologyforum.org/article/257
Adiposidad paterna en exceso antes del embarazo se asocia con mayor probabilidad de hepatopatía esteatósica asociada a la disfunción metabólica en los descendientes mediada por el IMC infantil en exceso #parents #MASLD gut.bmj.com/content/earl...
Webinar Series promotional graphic from EASD Early Career Academy. It lists: Date - 5 March 2026, 16:30 CET; Guest - Prof. Amalia Gastaldelli, National Research Council, Italy; Topic - “Could we change the course of MASLD - what is available and what is in the pipeline?” The EASD logo appears at the bottom left and the website easd.org/academy at the bottom right.
🎥This week, our EASD Early Career Academy is hosting a #webinar w. Prof. Amy Gastaldelli, co-author of the @easlnews.bsky.social Guidance on the full steatotic #liverdisease trajectory on #MASLD: treatments & what's next.
📅 5 March 2026 |🕛 16:30 CET
👉 Register now: us06web.zoom.us/webinar/regi...
#microbiome #MASLD #health #SDGs
The neonicotinoid pesticide nitenpyram
damages the intestinal mucosa,
disturbs intestinal flora,
and increases Desulfovibrio gut microbiota.
Excessive H2S produced by Desulfovibrio
causes non-alcoholic steatohepatitis.
.
www.sciencedirect.com/science/arti...
Honoured to receive the 🏅 Best Poster Presentation award 🏅at the #EASL #SLDSummit 2026 in Budapest 🇭🇺
A great opportunity to present and discuss data on platelet behaviour in #MASLD within an international scientific setting. Many thanks to all collaborators! 🙌
Presented data from my study at the #EASL #SLDSummit 2026 in Budapest 🇭🇺
I shared insights on #platelet activation and function 🧪 across different stages of #MASLD
A valuable opportunity for discussion and scientific exchange ✨️